Industry divided over Personal Care Products Safety Act

Published: 17-May-2017

The Feinstein Collins bill was re-introduced last week. While it would give the FDA greater powers over cosmetics regulation, it does not have full support from industry bodies with some favouring the Sessions bill instead

You need to be a subscriber to read this article.
Click here to find out more.

US Senator Dianne Feinstein and Senator Susan Collins re-introduced the Personal Care Products Safety Act (PCPA) bill last week.

The bill was reintroduced in the 115th Session of Congress, after it became inactive at the end of the last congressional session.

The PCPA seeks to amend

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Cosmetics Business.

Subscribe now Already a subscriber? Sign in here.

You may also like